{"id":"W2923651250","doi":"10.1093/jnci/djz032","title":"Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer","year":2019,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Yonsei University College of Medicine; University of Florida Health; Cancer Institute, University of Pittsburgh; Weill Cornell Medical College; Peter MacCallum Cancer Centre; Yonsei University; Department of Medicine, Georgetown University; KU Leuven; NRG Oncology; University of Ottawa; Allegheny Health Network; VCU Massey Cancer Center; Virginia Commonwealth University; National Cancer Institute; Kaiser Permanente; Breast Cancer Research Foundation; Pennsylvania Department of Health; AstraZeneca; Georgetown University; Genentech; University of Pittsburgh; Amgen","keywords":"Trastuzumab; Medicine; Internal medicine; Oncology; Breast cancer; Hazard ratio; Confidence interval; Concordance; Stage (stratigraphy); Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001509844,0.0002925787,0.0004674757,0.0001295709,0.00009717487,0.0002728507,0.00020529,0.0002378654,0.0006434844],"category_scores_gemma":[0.0009737845,0.0001340229,0.0003661874,0.0001422986,0.000203027,0.0002024012,0.0002223114,0.000460212,0.0001274427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003192651,"about_ca_system_score_gemma":0.0003966949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005960024,"about_ca_topic_score_gemma":0.002292802,"domain_scores_codex":[0.9996082,0.0002727955,0.00001685867,0.00002873969,0.00003671437,0.00003681641],"domain_scores_gemma":[0.9996035,0.0001161129,0.0001076966,0.00002641848,0.00002368521,0.0001226216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5101273,0.003697373,0.3373235,0.000608974,0.001894831,0.0002703613,0.0001588023,0.002593839,0.01293204,0.000236578,0.001904452,0.128252],"study_design_scores_gemma":[0.08495162,0.1684635,0.7285643,0.0001549807,0.001823306,0.0004646685,0.0001355166,0.005861306,0.002652541,0.0006515888,0.006249171,0.0000276049],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983006,0.001149531,0.00003493203,0.00009552413,0.00001151125,0.00004783165,0.00008535,0.000002899433,0.00027182],"genre_scores_gemma":[0.9984708,0.0004140535,0.0001117307,0.0001188568,0.00002599534,0.00006347864,0.0003783383,0.000001092948,0.0004156622],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001509844,"threshold_uncertainty_score":0.007984936,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0748041909655118,"score_gpt":0.427290851404628,"score_spread":0.3524866604391161,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}